Immune Design Corp. (NASDAQ: IMDZ)

Rowley Law PLLC is investigating potential claims against Immune Design Corp. (NASDAQ: IMDZ) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Merck Sharp & Dohme Corp. (NYSE: MRK). Stockholders will receive $5.85 for each share of Immune Design Corp. stock that they hold. The transaction is valued at approximately $300 million and is expected to close in the second quarter of 2019.

If you are an Immune Design Corp. stockholder and are interested in obtaining additional information regarding this investigation, please fill in the contact form on this page. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).